自己注射の世界市場:企業概要・規模・シェア・成長・動向・予測(~2024年)

【英語タイトル】Global Self-Injections Market Analysis : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Data Bridge Market Researchが出版した調査資料(DBMR810289)・商品コード:DBMR810289
・発行会社(調査会社):Data Bridge Market Research
・発行日:2017年9月
・ページ数:350
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD4,200 ⇒換算¥466,200見積依頼/購入/質問フォーム
Corporate UserUSD5,400 ⇒換算¥599,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、自己注射の世界市場について調査・分析し、自己注射の世界市場動向、市場予測、セグメント別分析、自己注射市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

The Global Self-Injections Market is accounted to reach USD 119.5 billion by 2024, from USD 23.4 billion in 2016, it is growing at the CAGR of 22.6 % in the forecast period 2017 to 2024..
The exponential growth is owing to multiple factors but the most prominent is development of biologic drugs for the treatment of autoimmune diseases, chronic diseases include heart disease, diabetes, stroke, and chronic respiratory problems.

The key market players for Global Self-Injections Market are listed below:

• Abbvie, Inc.,
• Antares Pharma,
• 3M,
• Becton Dickinson & Company
• , Baxter International Inc.,
• Penjet Corporation,
• PharmaJet,
• GerresheimerAG,Pfizer Inc.,
• Terumo Corporation,
• Mylan N.V.,
• SHL Group,
• Bespak,
• Janssen Biotech Inc.,
• Insulet Corporation,
• Unilife Corporation,
• West Pharmaceutical Services, Inc.,
• Ypsomed,
• Eli lilly and Company,
• Haselmeier AG,
• Alkermes,
• AptarPharma,
• Credence MedSystems, Inc.,
• SchottAG,
• Ypsomed,
• Owen Mumford Ltd.,
• Glide Technologies,

The market is further segmented into:
• Type
• Application
• End User
• Geography

The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting injection formulations. The conventional drug delivery segment is categorized into solutions, reconstituted/lyophilized formulations, suspensions and emulsions.
The novel drug delivery formulations market is segmented into colloidal dispersions, and microparticles. Colloidal dispersions market is further categorized into liposomes, niosomes, and polymeric/mixed micelles, and nano particles. Also, nanoparticles market is further segmented into nanosuspensions, nanoemulsions/microemulsions, and solid-lipid nanoparticles.

Based on therapeutic application, the market is segmented intoautoimmunediseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others. The market is also segmented based on dosage formintosingle dose and multi-dose.

Based on of route of administration, the market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.

Based on end-user, the market is segmented into patient, physicians, home care settings and, others. The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies.
Based on geography, the Global Self-Injections market is segmented into geographical regions, such as,
• North America,
• Europe,
• Asia-Pacific,
• South America
• Middle East & Africa

Covered in this report
The report covers the present scenario and the growth prospects of the Global Self-Injections market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table Of Contents
1. Introduction

1.1. Overview Of Global Self-Injection Market
1.2. Currency And Pricing
1.3. Limitation
1.4. Markets Covered

2. Market Segmentation

2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. Market Overview

3.1. Drivers

3.1.1. Rising Cases Of Chronic Diseases
3.1.2. Rising Demand Of Self-Injection Devices
3.1.3. Growth Of Biologics Market
3.1.4. Technological Advancements And Innovations In Drug Delivery Market

3.2. Restraints

3.2.1. High Cost Of Development
3.2.2. Strict Regulatory Framework

3.3. Opportunity

3.3.1. Increasing Demand For Generic And Biosimilar Drugs

3.3.1.1. Generics
3.3.1.2. Biosimilars

3.3.2. Increasing Demand For Contraceptive Injectables
3.3.3. Increasing Demand For Self-Administration Of Drugs

3.4. Challenges

3.4.1. Alternative Route Of Drug Administration
3.4.2. Product Recall
3.4.3. Stability Of Products
3.4.4. Sterility Of Injections

4. Executive Summary

5. Premium Insights

6. Global Self-Injection Market, Regulatory

6.1. Overview
6.2. U.S. Fda Approval
6.3. Ce Marking (European Conformity)

7. Global Self-Injection Market, Reimbusement

7.1. Overview
7.2. Reimbursement Scenario

8. Global Self-Injection Market, By Type

8.1. Overview

8.2. Global Self-Injection Market, By Product Type

8.2.1. Needle Free Injectors (Nfi)

8.2.1.1. Needle Free Injectors, By Product
8.2.1.2. Needle Free Injectors, By Technology Laser Based Needle Free Injectors:Vibration Based Needle Free Injectors:
8.2.1.3. Needle Free Injectors, By Usability Reusable Needle-Free Injectors Disposable Needle-Free Injectors

8.2.2. Auto Injectors

8.2.2.1. Auto Injectors, By Product Fillable Auto Injectors Pre-Filled Auto Injectors
8.2.2.2. Auto Injectors, By Technology Automated Auto Injectors Manual Auto Injectors
8.2.2.3. Auto Injectors, By Design Standardized Auto Injectors Customizedauto Injectors
8.2.2.4. Auto Injectors, By Usability Reusable Auto Injectors Disposable Auto Injectors

8.2.3. Pen Injectors

8.2.3.1. Pen Injectors, By Product Single Chambered Pen Injectors Dual Chambered Pen Injectors
8.2.3.2. Pen Injectors, By Design Standard Pen Injectors Customized Pen Injectors
8.2.3.3. Pen Injectors, By Usability Reusable Pen Injectors Disposable Pen Injectors

8.2.4. Wearable Injectors

9. Global Self-Injection Market, By Application

9.1. Overview

9.2. Global Self-Injection Market, By Application

9.3. Hormonal Disorders

9.3.1. Self-Injections For Diabetes
9.3.2. Self-Injectionsfor Anemia
9.3.3. Reproductive Health Disease
9.3.4. Osteoporosis
9.3.5. Growth Hormone Disorders (Ghd)

9.4. Oncology

9.5. Autoimmune Diseases

9.5.1. Rheumatoid Arthritis
9.5.2. Multiple Sclerosis
9.5.3. Crohn’S Diseases
9.5.4. Psoriasis
9.5.5. Other Autoimmune Diseases

9.6. Orphan Disease

9.7. Other Applications

9.7.1. Pain Management
9.7.2. Allergy Treatment
9.7.3. Aesthetic Treatments
9.7.4. Hepatitis C
9.7.5. Hemophilia

10. Global Self-Injection Market, By Usage Pattern

10.1. Overview
10.2. Curative Care
10.3. Immunizations
10.4. Other Usage Pattern

11. Global Self-Injection Market, By Mode Of Administration

11.1. Overview
11.2. Skin
11.3. Circulatory/ Muskoskeletal
11.4. Organs
11.5. Central Nervous System

12. Global Self-Injection Market, By End User

12.1. Overview
12.2. Hospitals And Clinics
12.3. Home Healthcare Settings
12.4. Research Laboratories
12.5. Pharmaceutical And Biotechnological Companies
12.6. Other End User

13. Global Self-Injection Market, By Distribution Channel

13.1. Overview
13.1.1. Hospital Pharmacy
13.1.2. Pharmacy Stores
13.1.3. Direct Tender
13.1.4. Online Pharmacy

14. Global Self-Injection Market, By Geography

14.1. Overview

14.2. North America

14.2.1. U.S.
14.2.2. Canada
14.2.3. Mexico

14.3. Europe

14.3.1. Germany
14.3.2. France
14.3.3. Uk
14.3.4. Switzerland
14.3.5. Spain
14.3.6. Italy
14.3.7. Netherlands
14.3.8. Russia
14.3.9. Turkey
14.3.10. Belgium
14.3.11. Rest Of Europe

14.4. Asia-Pacific

14.4.1. Japan
14.4.2. China
14.4.3. South Korea
14.4.4. India
14.4.5. Australia
14.4.6. Singapore
14.4.7. Thailand
14.4.8. Malaysia
14.4.9. Indonesia
14.4.10. Philippines
14.4.11. Rest Of Asia-Pacific

14.5. South America

14.5.1. Brazil
14.5.2. Rest Of South America

14.6. Mea

14.6.1. South Africa
14.6.2. Rest Of Mea

15. Global Self Injection Market, Company Landscape

15.1. Company Share Analysis: Global
15.2. Company Share Analysis: North America
15.3. Company Share Analysis: Europe
15.4. Company Share Analysis: Asia-Pacific

16. Company Profiles

16.1. Elcam Medicalcompany Overview

16.1.1. Elcam Medical: Company Snapshot
16.1.2. Product Portfolio
16.1.3. Recent Developments

16.2. Bespak (Subsidiary Of Consort Medical Company)

16.2.1. Company Overview
16.2.2. Bespak: Revenue Analysis
16.2.3. Product Portfolio
16.2.4. Recent Developments

16.3. Sanofi

16.3.1. Company Overview
16.3.2. Sanofi : Revenue Analysi
16.3.3. Product Portfolio
16.3.4. Recent Developments

16.4. Sandoz International Gmbh

16.4.1. Company Overview

16.5. Sandoz International Gmbh: Revenue Analysis

16.5.1. Product Portfolio
16.5.2. Recent Developments

16.6. Unilife Corporation

16.6.1. Company Overview
16.6.2. Unilife Corporation: Revenueanalysis
16.6.3. Product Portfolio
16.6.4. Recent Developments

16.7. West Pharmaceutical Services, Inc

16.7.1. Company Overview
16.7.2. West Pharmaceutical Services, Inc: Revenue Analysis
16.7.3. Product Portfolio
16.7.4. Recent Developments

16.8. Pfizer Inc.

16.8.1. Company Overview
16.8.2. Pfizer Inc: Revenue Analysis
16.8.3. Product Portfolio
16.8.4. Recent Developments

16.9. Impax Laboratories, Inc.

16.9.1. Company Overview
16.9.2. Impax Laboratories, Inc: Revenue Analysis
16.9.3. Product Portfolio
16.9.4. Recent Developments

16.10. Penjet Corporation

16.10.1. Company Overview
16.10.2. Penjet Corporation: Company Snapshot
16.10.3. Product Portfolio
16.10.4. Recent Developments

16.11. Crossject Needle-Free Injection Systems

16.11.1. Company Overview
16.11.2. Crossject Needle-Free Injection Systems: Company Snapshot
16.11.3. Product Portfolio
16.11.4. Recent Developments

16.12. Wilhelm Haselmeier Gmbh & Co. Kg

16.12.1. Company Overview
16.12.2. Haselmeier: Company Snapshot
16.12.3. Product Portfolio
16.12.4. Recent Developments

16.13. Antares Pharma

16.13.1. Company Overview
16.13.2. Antares Pharma: Revenue Analysis
16.13.3. Product Portfolio
16.13.4. Recent Developments

16.14. Becton, Dickinson And Company

16.14.1. Company Overview
16.14.2. Becton, Dickinson And Company: Revenue Analysis
16.14.3. Product Portfolio
16.14.4. Recent Developments

16.15. Gerresheimer Ag

16.15.1. Company Overview
16.15.2. Gerresheimer Ag: Revenue Analysis
16.15.3. Product Portfolio
16.15.4. Recent Developments

16.16. Mylan N.V

16.16.1. Company Overview
16.16.2. Mylan N.V.: Revenue Analysis
16.16.3. Product Portfolio
16.16.4. Recent Developments

16.17. Novo Nordisk

16.17.1. Company Overview
16.17.2. Novo Nordisk: Revenue Analysis
16.17.3. Product Portfolio
16.17.4. Recent Developments

16.18. Owen Mumford Ltd

16.18.1. Company Overview
16.18.2. Owen Mumford Ltd: Company Snapshot
16.18.3. Product Portfolio
16.18.4. Recent Developments

16.19. Pharmajet

16.19.1. Company Overview
16.19.2. Pharmajet: Company Snapshot
16.19.3. Product Portfolio
16.19.4. Recent Developments

16.20. Shl Group

16.20.1. Company Overview
16.20.2. Shl Group: Company Snapshot
16.20.3. Product Portfolio
16.20.4. Recent Developments

16.21. Ypsomed

16.21.1. Company Overview
16.21.2. Ypsomed: Revenue Analysis
16.21.3. Product Portfolio
16.21.4. Recent Developments

17. Related Reports

List Of Figures
Figure 1 Global Self Injectoin Market: Segmentation

Figure 2 Global Self-Injection Market: Geographic Scope

Figure 3 Global Self-Injection Market: Data Triangulation

Figure 4 Global Self-Injection Market: Research Snapshot

Figure 5 Global Self-Injection Market: Bottom Up Approach

Figure 6 Global Self-Injection Market: Top Down Approach

Figure 7 Global Self-Injection Market: Interview Demographics

Figure 8 Drivers, Restraints, Opportunities, And Challenges Of The Self-Injection Market

Figure 9 North America Dominated The Global Self-Injection Market In 2016 With 46.6% Share, Needle Free Injector Is The Dominating Product Type And Hormonal Disorder Is The Dominating Application Of Self-Injection Market

Figure 10 Technological Development And Increasing Prevalence Of Chronic Diseases Are Expected To Drive The Market For Self-Injection In The Forecast Period 2017 To 2024

Figure 11 Needle Free Injection Market Segment Is Expected To Account For The Largest Share Of The Global Self-Injection Market In 2017 & 2024

Figure 12 North America Is The Highest Growing And Most Profitable Revenue Pockets For Self-Injection Manufacturers In The Forecast Period To 2024

Figure 13 Global Self-Injection Market: By Product Type, 2016

Figure 14 Global Self-Injection Market: By Application, 2016

Figure 15 Global Self-Injection Market: By Usage Pattern, 2016

Figure 16 Global Self-Injection Market: By Mode Of Administration, 2016

Figure 17 Global Self-Injection Market Dominated By Hospital And Cliinics Segment

Figure 18 Global Self-Injection Market:By End-User, 2016

Figure 19 Global Self-Injection Market: By Distribution Channel, 2016

Figure 20 Global Self-Injection Market Snapshot (2016)

Figure 21 Global Self-Injection Market: By Geography (2016)

Figure 22 Global Self-Injection Market :By Country (2017)

Figure 23 Global Self-Injection Market By Country (2016 & 2024)

Figure 24 Global Self-Injection Market, By Product Type (2017 & 2024)

Figure 25 North America Self-Injection Market Snapshot (2016)

Figure 26 North America Self-Injection Market: By Geography (2016)

Figure 27 North America Self-Injection Market :By Country (2017 & 2024)

Figure 28 North America Self-Injection Market By Country (2016 & 2024)

Figure 29 North America Self-Injection Market, By Product Type (2017 & 2024)

Figure 30 Europeanself-Injection Market Snapshot (2016)

Figure 31 Europe Self-Injection Market: By Geography (2016)

Figure 32 Europeself-Injection Market :By Country (2017 & 2024)

Figure 33 Europeself Injectoin Market By Country (2016 & 2024)

Figure 34 Europeself-Injection Market,By Product Type (2017 & 2024)

Figure 35 Asia Pacific Self-Injection Market Snapshot(2016)

Figure 36 Asia Pacific Self-Injection Market: By Geography (2016)

Figure 37 Asia Pacific Self-Injection Market :By Country (2017 & 2024)

Figure 38 Asia Pacific Self-Injection Market, By Country, (2016 & 2024)

Figure 39 Asia Pacific Self-Injection Market, By Product Type (2017 & 2024)

Figure 40 South America Self-Injection Market Snapshot (2016)

Figure 41 South America Self-Injection Market: By Geography (2016)

Figure 42 South America Self-Injection Market : By Country (2017 & 2024)

Figure 43 South America Self-Injection Market By Country (2016 & 2024)

Figure 44 South America Self-Injection Market, By Product Type (2017 & 2024)

Figure 45 Mea Global Self-Injection Market Snapshot (2016)

Figure 46 Middle East And Africa Self-Injection Market: By Geography (2016)

Figure 47 Middle East And Africa Self-Injection Market : By Country (2017 & 2024)

Figure 48 Middle East And Africa Self-Injection Market By Country (2016 & 2024)

Figure 49 Middle East And Africa Self-Injection Market, By Product Type (2017 & 2024)

Figure 50 Global Self Injection Market: Company Share 2016 (%)

Figure 51 North America Self Injection Market: Company Share 2016 (%)

Figure 52 Europe Self Injection Market: Company Share 2016 (%)

Figure 53 Asia-Pacific Self Injection Market: Company Share 2016 (%)

【レポートのキーワード】

自己注射

★調査レポート[自己注射の世界市場:企業概要・規模・シェア・成長・動向・予測(~2024年)] (コード:DBMR810289)販売に関する免責事項を必ずご確認ください。
★調査レポート[自己注射の世界市場:企業概要・規模・シェア・成長・動向・予測(~2024年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆